Neurocrine Biosciences Inc (NBIX: NASDAQ)
$35.61 -0.47 | -1.3%
05/05/15 - 04:00 PM ET
1.02M / 1.09MVol / Avg. Vol:
35.88 / 36.08Open / Prev. Close:
35.08 - 36.71Today's Range:
12.6325 - 45.3652 Wk Range:
Portfolios with NBIX
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- ContributorHot Biotech Stocks Traded b...
- ContributorStocks With Big Insider Buy...
- Contributor5 Stocks Under-$10 Setting ...
- Contributor5 Drug Stock Winners of 2010
- UserKareem Portfolio
- UserSUPRATRADE Top 10 Micro Cap...
- UserBVF Inc.
- UserRAPTOR SPRTD-1110080822
Latest NBIX Headlines from TheStreet
- First Week of NBIX June 19th Options Trading 04.23.15 | 11:04 am
- Jim Cramer's 'Mad Money' Recap: Good Headlines Make All the Difference 03.30.15 | 08:03 pm
- Short Interest In Neurocrine Biosciences Drops 20.6% 03.11.15 | 03:03 pm
- Commit To Buy Neurocrine Biosciences At $17, Earn 30.2% Annualized Using Options 12.24.14 | 12:12 pm
- 2 Big-Volume Biotech Stocks to Trade for Breakouts 09.25.14 | 09:09 am
- The Best Hedge Fund You've Never Heard Of and Its Top 5 Stock Picks 08.26.14 | 02:08 pm
- NBIX Crosses Above Key Moving Average Level 08.06.14 | 11:08 am
- Commit To Purchase Neurocrine Biosciences At $12, Earn 27.6% Annualized Using Options 07.08.14 | 11:07 am
- Bullish Two Hundred Day Moving Average Cross - NBIX 05.08.14 | 11:05 am
- Neurocrine Biosciences Inc. Stock Downgraded (NBIX) 04.16.14 | 11:04 am
Press Releases for NBIX
- Neurocrine Biosciences, Inc. Announces Appointment Of Dr. Bill Aurora As Vice President, Medical Affairs - PR Newswire 05.04.15 | 04:05 pm
- Neurocrine Biosciences To Present At The Deutsche Bank 40th Annual Health Care Conference - PR Newswire 04.30.15 | 01:04 pm
- Neurocrine Biosciences Announces Conference Call And Webcast To Report First Quarter 2015 Results - PR Newswire 04.23.15 | 01:04 pm
- Neurocrine Biosciences And Mitsubishi Tanabe Pharma Announce Agreement To Develop And Commercialize VMAT2 Inhibitor NBI-98854 For Movement Disorders In Japan And Other Select Asian Markets - PR Newswire 03.31.15 | 10:03 pm
- Neurocrine Biosciences To Present At The Barclays Global Healthcare Conference Live Audio Webcast Will Be On March 10, 2015 - PR Newswire 03.03.15 | 01:03 pm
- Neurocrine Biosciences To Present At Cowen And Company's 35th Annual Health Care Conference - PR Newswire 02.24.15 | 01:02 pm
- Neurocrine Biosciences, Inc. Announces Exercise In Full Of Underwriters' Option To Purchase Additional Shares - PR Newswire 02.20.15 | 07:02 am
- Neurocrine Biosciences, Inc. Prices Public Offering Of Common Stock - PR Newswire 02.19.15 | 07:02 am
- Neurocrine Biosciences, Inc. Announces Proposed Public Offering Of $225 Million Of Common Stock - PR Newswire 02.17.15 | 04:02 pm
- Neurocrine Biosciences To Present At The 2015 Leerink Global Healthcare Conference - PR Newswire 02.04.15 | 01:02 pm
Partner Headlines for NBIX
- Lightning Round: This has gotten too hot - CNBC 03.31.15 | 11:03 am
- Neurocrine initiated with an Overweight at JPMorgan - Fly On The Wall 03.19.15 | 05:03 am
- Neurocrine initiated with an Overweight at Barclays - Fly On The Wall 03.04.15 | 05:03 am
- Mid-Day Market Update: Five Below Shares Gain On Upbeat Results; Urban Outfitters Tumbles - Benzinga 09.10.13 | 12:09 pm
- Can the Recent Uptrend Continue for Neurocrine Biosciences, Inc. (NBIX)? - Tale of the Tape - Zacks 09.06.13 | 11:09 am
- Neurocrine Biosciences Earnings: Here’s Why Investors are Selling Shares Now - Wall St. Cheat Sheet 05.02.13 | 08:05 am
- Healthcare Biz Recap: Complete Genomics CUTS Costs, Abbott Labs Teams Up - Wall St. Cheat Sheet 06.06.12 | 08:06 am
- Neurocrine Biosciences (NBIX) - Bull of the Day - Zacks 11.02.11 | 01:11 am
- Piper Jaffray Maintains Overweight on Neurocrine Biosciences (NBIX) - Benzinga 03.25.11 | 09:03 am
- Unconfirmed Rumors Circulate that Neurocrine Biosciences Inc. (NBIX) will be taken out by Eli Lilly & Co. (LLY) at $17.00 a share - Benzinga 12.22.10 | 09:12 am